Skip to main content
CriticalFDAfda-F-1442-2019UNDECLARED ALLERGEN

Deshi Golden Raisin, packaged in 3.5 oz, 7 oz. and 14 oz. clear plastic

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
15
Recall Date
May 9, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1442-2019.

NYS found elevated levels of undeclared Sulfites in dried Deshi Golden Raisins

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1442-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Deshi Distributors, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1442-2019.

DESHI DISTRIBUTORS, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Deshi Distributors, Llc Recall FAQ

Deshi Distributors, Llc is the subject of a food safety report: Deshi Golden Raisin, packaged in 3.5 oz, 7 oz. and 14 oz. clear plastic. The notice was published on May 9, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 15 units are potentially affected.